ChrysCapital
ChrysCapital is India's largest homegrown private equity firm, founded 1999, managing ~$8.5B across ten PE funds plus the Clarus long-only public-markets vehicle, investing in control and growth deals across six Indian sectors via the in-house Enhancin value-creation platform.
- Company typePrivate
- Founded1999
- HeadquartersPort Louis, Mauritius
- Headcount51–100
- GTM typeB2B
- OfferingServices
What ChrysCapital does
ChrysCapital is India's largest homegrown private equity firm, founded in 1999 by Ashish Dhawan and headquartered in Mumbai with fund-administration offices in Mauritius. The firm invests across six core verticals — Consumer, Enterprise Technology, Financial Services, Healthcare & Life Sciences, Manufacturing, and New Economy — through growth and control/buyout transactions. Since inception it has raised approximately $8.5 billion across ten PE funds, deployed roughly $4.5 billion into 100+ investments, and realized approximately $6.5–7 billion across 75–80 exits. The largest fund, ChrysCapital X, closed at $2.2 billion in November 2025 and is the largest India-focused PE fund ever raised.
The firm's product platform is anchored on its flagship private equity fund series, supplemented by the Clarus long-only Indian public-markets fund (launched 2023, ~$200M) and the Enhancin portfolio operations group (est. 2017), which delivers measurable value-add to portfolio companies across revenue enhancement, operational improvement, people/organization, and operational due-diligence workstreams. The firm sells institutional capital: it raises from global sovereign wealth funds, pensions, insurers, endowments, foundations, and asset managers, and—starting with Fund X—domestic Indian family offices and institutions. Deal sourcing runs through proprietary networks plus a deep bench of sector-specialist operating advisors (Sanjay Jalona ex-LTI CEO, Harsh Mariwala, Ramesh Iyer ex-Mahindra Finance, Ajay Kaul ex-Domino's India).
Revenue is generated from management fees on committed and invested capital across the fund series plus performance-based carried interest on profitable exits. The firm itself is privately held with no public ticker, and operating geographies span India (primary), US-based portfolio companies, and a global LP base. The senior investment team averages more than 20 years at ChrysCapital following a successful 2011–2012 founder transition.
ChrysCapital firmographics
Firmographics- Name
- ChrysCapital
- Legal name
- ChrysCapital LLP
- Website
- http://www.chryscapital.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ChrysCapital is India's largest homegrown private equity firm, founded 1999, managing ~$8.5B across ten PE funds plus the Clarus long-only public-markets vehicle, investing in control and growth deals across six Indian sectors via the in-house Enhancin value-creation platform.
- Ownership category
- akta.pro rank
Where ChrysCapital is headquartered
LocationHeadquarters
- HQ city
- Port Louis
- HQ country
- Mauritius
- HQ region
- Africa
Offices3 records
Markets served
ChrysCapital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Private Equity Fund Management Fees: Recurring management fees on committed and invested capital across ChrysCapital's PE funds (Funds I through X), generating stable annual fee income. ChrysCapital has raised $5 billion across nine PE funds and added a $2.2 billion tenth fund (Fund X), plus the long-only Clarus vehicle.
- Carried Interest / Investment Realizations: Performance-based carried interest on profitable exits from portfolio companies. ChrysCapital has fully exited its first six funds and realized approximately $7 billion across 80 exits (per About Us page). Recent updates cite $6.5 billion realized from 75+ exits. Notable exits include LiquidHub to CapGemini ($500M, 40% IRR/3.8x), Infogain to Apax ($900M, 42% IRR/6.5x), GeBBS Healthcare to EQT (>$800M).
- Public-Markets Investment Returns: Returns from ChrysCapital's public-market investment fund deployed in BFSI and listed equities. The public-market vehicle makes concentrated bets alongside PE investments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | ChrysCapital X (Fund X) - largest ever India-focused PE fund |
| Other | Multi-year contract | ChrysCapital IX |
| Other | Multi-year contract | Clarus (Long-Only Public Markets Fund) |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
ChrysCapital product offering
Product offeringCore offering
ChrysCapital is India's largest homegrown private equity firm managing a series of PE funds (most recently Fund X at $2.2 billion) that make growth and control investments in six core sectors: Consumer, Enterprise Technology, Financial Services, Healthcare & Life Sciences, Manufacturing, and New Economy. The firm also operates Clarus, a long-only public markets fund, and Enhancin, an in-house portfolio operations group that delivers revenue enhancement, operational improvement, and people/organization value-add services to portfolio companies.
Product overview
ChrysCapital is India's largest homegrown private equity firm (founded 1999), offering a platform-plus-modules architecture of investment products and value-added services rather than a single software product. The core platform is the flagship private equity fund series (most recently ChrysCapital X at $2.2 billion), complemented by the ChrysCapital Clarus long-only public markets fund and the Enhancin portfolio operations group, which delivers value creation services to portfolio companies. The responsible investment / ESG framework is layered across all funds and sits alongside the firm's Great Place to Work certification and memberships in UN Global Compact, PRI, ESGDC, ILPA DIA, IVCA, WinPE, FICCI, US-ISPF, and PEVC CFO. Together, the ChrysCapital flagship PE funds, ChrysCapital Clarus, and Enhancin constitute an integrated investment platform targeting control and growth investments across six core sectors: Consumer, Enterprise Technology, Financial Services, Healthcare & Life Sciences, Manufacturing, and New Economy.
Differentiator
Problem solved
Functional benefit
Brands
- Enhancin: ChrysCapital's portfolio value creation / operations group, established in 2017, working across minority and control investments on revenue enhancement, operational improvement, people and organization, and operational due diligence.
- Clarus
Products and services
- ChrysCapital X (Fund X)
- ChrysCapital Clarus
- Enhancin Portfolio Operations Group
- ChrysCapital Responsible Investment / ESG Framework
Quantifiable outcome
- ~$7 billion realized across 80 exits (per About Us); updated to $6.5 billion from 75+ exits in March 2026 reporting
- +5 more outcomes
Companies that use ChrysCapital
Customer profileNamed customers14 records
Segments6 records
Ideal customer profiles2 records
ChrysCapital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ChrysCapital partnerships and signals
Strategic signalScale indicators11 records
Recent moves7 records
Expansion highlights6 records
ChrysCapital competitors and assessment
Company assessmentDirect peers
- ICICI Venture: ICICI Venture is one of India's oldest and largest PE firms, backed by the ICICI Group, with a multi-sector India PE/VC strategy closely comparable to ChrysCapital's diversified sector approach.
- True North (India): True North is a leading India-focused PE firm making control and minority growth investments across financial services, healthcare, consumer and technology — a direct competitor to ChrysCapital for India mid-market control deals.
- Everstone Capital: Everstone is one of India's largest homegrown PE firms focused on control and growth investments across consumer, financial services, healthcare and technology — directly comparable to ChrysCapital's six-sector India PE strategy.
Broad incumbents
- General Atlantic (India): General Atlantic operates a major growth-equity platform in India across technology, financial services and consumer — a comparable growth-investing strategy targeting many of the same sectors as ChrysCapital.
- Advent International (India): Advent International is a global PE firm with an active India franchise across financial services, healthcare and industrials — competing with ChrysCapital for cross-border control buyouts and growth deals in India.
- Warburg Pincus India: Warburg Pincus is a long-standing global PE investor with deep India presence across financial services, consumer and technology — comparable to ChrysCapital's growth and control investment approach in India.
- Carlyle India: Carlyle operates a substantial India platform investing across consumer, financial services, healthcare and technology — a comparable diversified India PE strategy from a global mega-sponsor.
- Blackstone India: Blackstone runs the largest India-dedicated PE strategy (BCP IX) and is a leading competitor for control investments in Indian technology, financial services, and consumer — comparable in sector overlap but with materially larger AUM.
- KKR India: KKR operates a major India PE platform across buyout, growth and infrastructure, competing with ChrysCapital for large control deals and offering similar sector breadth with much larger global AUM.
- Bain Capital India: Bain Capital has built a large India-focused PE business across consumer, financial services, healthcare and technology, directly competing with ChrysCapital for control deals in the same sectors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ChrysCapital social profiles
Digital presenceChrysCapital compliance and trust
Trust signalCompliance5 records
ChrysCapital financial estimates
Financial estimateRevenue estimate
Valuation estimate
ChrysCapital leadership team
Management profileNumber of profiles
Profiles19 records
ChrysCapital subsidiaries and ownership
Company hierarchySubsidiaries5 records
ChrysCapital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ChrysCapital M&A and investment
M&A and investmentM&A6 records
Investments70 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ChrysCapital
What does ChrysCapital do?
ChrysCapital is India's largest homegrown private equity firm managing a series of PE funds (most recently Fund X at $2.2 billion) that make growth and control investments in six core sectors: Consumer, Enterprise Technology, Financial Services, Healthcare & Life Sciences, Manufacturing, and New Economy. The firm also operates Clarus, a long-only public markets fund, and Enhancin, an in-house portfolio operations group that delivers revenue enhancement, operational improvement, and people/organization value-add services to portfolio companies.
Is ChrysCapital a public or private company?
ChrysCapital is a private company. It is classified as management employee owned and is currently operating.
When was ChrysCapital founded?
ChrysCapital was founded in 1999. It employs 51 to 100 people.
Where is ChrysCapital based?
ChrysCapital is headquartered in Port Louis, Mauritius, in the Africa region.
How does ChrysCapital make money?
Three revenue lines are on record. Private Equity Fund Management Fees are the primary driver. The others are carried Interest / Investment Realizations and public-Markets Investment Returns.
Who are ChrysCapital's main competitors?
Direct peers on record are ICICI Venture, True North (India) and Everstone Capital. Broad incumbents are General Atlantic (India), Advent International (India), Warburg Pincus India, Carlyle India, Blackstone India, KKR India and Bain Capital India.
Does ChrysCapital have an API?
No public API is recorded for ChrysCapital.